Jonny Cochrane Limited

	Page
Abridged Balance Sheet	1—2
Notes to the Abridged Financial Statements	3—5

Registered number: 08633069

		2025		2024
	Notes	£	£	£	£
FIXED ASSETS
Intangible Assets			22,744		-
Tangible Assets	4		5,088		5,986
Investments	5		1,800,665		1,800,665

			1,828,497		1,806,651
CURRENT ASSETS
Debtors		3,997,346		3,304,744
Cash at bank and in hand		177		269

		3,997,523		3,305,013
Creditors: Amounts Falling Due Within One Year		(100,139 )		(112,782 )

NET CURRENT ASSETS (LIABILITIES)			3,897,384		3,192,231

TOTAL ASSETS LESS CURRENT LIABILITIES			5,725,881		4,998,882

Creditors: Amounts Falling Due After More Than One Year	6		(3,455,657 )		(2,697,346 )

PROVISIONS FOR LIABILITIES
Deferred Taxation			(913 )		(1,137 )

NET ASSETS			2,269,311		2,300,399

CAPITAL AND RESERVES
Called up share capital	8		101		101
Revaluation reserve	10		(9,256 )		-
Profit and Loss Account			2,278,466		2,300,298

SHAREHOLDERS' FUNDS			2,269,311		2,300,399

Page 1

Page 2

Jonny Cochrane Limited

Abridged Balance Sheet (continued)

As At 31 March 2025

For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

All of the company's members have consented to the preparation of an Abridged Balance Sheet for the year end 31 March 2025 in accordance with section 444(2A) of the Companies Act 2006.

On behalf of the board

Dr J Cochrane

Director

3 September 2025

The notes on pages 3 to 5 form part of these financial statements.

1. General Information

Jonny Cochrane Limited is a private company, limited by shares, incorporated in England & Wales, registered number 08633069 . The registered office is 9 Clover Grove, Barrow Gurney, Bristol, BS48 3AJ.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006

2.2. Intangible Fixed Assets and Amortisation - Other Intangible

Other intangible assets are investments in cryptocurrencies. Cryptocurrency investments are initially recognised at cost, and subsequently revalued to fair value at each year end.

2.3. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant & Machinery

15% on reducing balance

2.4. Financial Instruments

Debt instruments (other than those wholly repayble or recievable within one year), including loans and other accounts recievable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method.

Debt instruments that are payable and recievable within one year, typically trade debtors and creditors, are mesured, initially and subsequently at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short term instrument constitue a finaciang transaction, like the payment of trade debt defferd beyond the normal business terms or financied at a rate of interest that is not a market rate or in the case of an out-right short-term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a maret rate of interest for a similar debt instrument and subsequently at amortised cost.

Financial assests that are measured at cost and amortised costs are assessed at the end of each reporting period for the objective evidence of impairment. If objective evidence of impariment is found, an impairment loss is recognised in the Profit and Loss Account.

For finanical assets measured at amortised cost, the impariment loss is measured at the difference between an asset’s carrying amount and the present value of estimated cash flows discounted at the asset’s orginal effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

2.5. Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.

Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.

Page 3

Page 4

Jonny Cochrane Limited

Notes to the Abridged Financial Statements (continued)

For The Year Ended 31 March 2025

2.6. Investments in Subsidiaries

Investments in subsidiary undertakings are recognised at cost.

2.7. Cash and Cash Equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Cash and cash equivalents are shown net of bank overdrafts that are repayable on demand.

3. Average Number of Employees

Average number of employees during the year was as follows: NIL (2024: NIL)

4. Tangible Assets

	Total
	£
Cost
As at 1 April 2024	16,405

As at 31 March 2025	16,405

Depreciation
As at 1 April 2024	10,419
Provided during the period	898

As at 31 March 2025	11,317

Net Book Value
As at 31 March 2025	5,088

As at 1 April 2024	5,986

5. Investments

	Total
	£
Cost
As at 1 April 2024	1,800,665

As at 31 March 2025	1,800,665

Provision
As at 1 April 2024	-

As at 31 March 2025	-

Net Book Value
As at 31 March 2025	1,800,665

As at 1 April 2024	1,800,665

6. Creditors: amounts falling due after five years

Of the creditors falling due after more than one year the following amounts are due after more than five years.

	2025		2024
	£		£
Bank loans	913,663		1,020,355

Page 4

Page 5

Jonny Cochrane Limited

Notes to the Abridged Financial Statements (continued)

For The Year Ended 31 March 2025

7. Secured Creditors

Of the creditors the following amounts are secured.

	2025		2024
	£		£
Bank loans and overdrafts	1,438,790		1,532,445

8. Share Capital

	2025	2024
	£	£
Allotted, Called up and fully paid	101	101

9. Directors Advances, Credits and Guarantees

Included within Debtors are the following loans to directors:

	As at 1 April 2024	Amounts advanced	Amounts repaid	Amounts written off	As at 31 March 2025
	£	£	£	£	£
Dr Jonathan Cochrane	-	424	(312 )	-	112

Interest is charged on loan balances above £10,000 at the HMRC approved interest rate of 2.25%.

10. Reserves

	Revaluation Reserve
	£
Surplus on revaluation	(9,256 )

As at 31 March 2025	(9,256 )

11. Related Party Transactions

During the year ended 31 March 2025, the company made loan repayments of £14,074 to a related party. The balance outstanding at the end of this financial year was £2,658 (2024: £16,732) and is shown within creditors falling due within one year. This loan is interest free and repayable on demand.

During the year, the company advanced £692,491 (2024: £440,830) to another company of which Dr J Cochrane is director and shareholder. The total amount outstanding at the end of the financial year is £3,997,234 (2024: £3,304,744). This loan is shown within debtors in these financial statements and is repayable on demand.

Page 5